Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leaders
Indian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They highlight the importance of regulatory reforms and a strong ecosystem for research and development. Industry executives mention that the next decade will be critical for this transformation and urge companies to capitalize…
The Economic Times ·
The Economic Times
